We are live on ! Find out more
PAVM icon

PAVmed
PAVM

23 hedge funds and large institutions have $654K invested in PAVmed in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more funds holding

Funds holding: 19 → 23 (+4)

1.35% less ownership

Funds ownership: 10.77% → 9.41% (-1.4%)

38% less capital inflows, than outflows

Capital inflows: $125K | Capital outflows: $203K

75% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 8

Holders
23
Holders Change
+4
Holders Change %
+21.05%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
8
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
First Manhattan
First Manhattan
New York
+$98.5K
2
UBS Group
UBS Group
Switzerland
+$12.6K
3
Exencial Wealth Advisors
Exencial Wealth Advisors
Oklahoma
+$10.7K
4
Group One Trading
Group One Trading
Illinois
+$2.19K
5
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$798

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$197K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$2.98K
3
BlackRock
BlackRock
New York
-$2.22K
4
Wells Fargo
Wells Fargo
California
-$443
5
Bank of America
Bank of America
North Carolina
-$207

PAVM Hedge Fund Activity: Q4 2024 in Review

23 of the 7,623 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2024, worth a combined $654K — down 53% from $1.38M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PAVM positions and 0 closed out — a net gain of 5 holders — while 2 added to existing stakes and 8 trimmed.

The largest buyer was First Manhattan, adding an estimated $98.5K. The largest seller was Vanguard Group, cutting an estimated $197K.

  • 23 institutional investors held PAVmed (PAVM) as of Q4 2024, up from 19 in Q3 2024.
  • Funds reported $654K of PAVmed stock for Q4 2024, down 53% quarter-over-quarter.
  • 5 funds opened new PAVmed positions in Q4 2024 and 0 closed out, a net change of +5 holders.
  • The largest PAVmed buyer in Q4 2024 was First Manhattan, an estimated $98.5K added.
  • The largest PAVmed seller in Q4 2024 was Vanguard Group, an estimated $197K sold.

Based on aggregated 13F filings for Q4 2024.